Universal Biosensors (ASX:UBI) signed a non-exclusive deal with Henry Schein, an American distributor of dental and medical supplies, according to a Friday filing with the Australian bourse.

The agreement covers the distribution of the company's coagulation monitoring device, Xprecia Prime, throughout the US, the filing said.

The deal is for a year with provisions for annual extensions by agreement, as per the filing.